Your browser doesn't support javascript.
loading
Persistent clonal cytogenetic abnormality with del(20q) from an initial diagnosis of acute promyelocytic leukemia.
Fujioka, Machiko; Itonaga, Hidehiro; Kato, Takeharu; Nannya, Yasuhito; Hashimoto, Miki; Kasai, Sachie; Toriyama, Eo; Kamijo, Rena; Taguchi, Masataka; Taniguchi, Hiroaki; Sato, Shinya; Atogami, Sunao; Imaizumi, Yoshitaka; Hata, Tomoko; Moriuchi, Yukiyoshi; Ogawa, Seishi; Miyazaki, Yasushi.
Afiliação
  • Fujioka M; Department of Hematology, Nagasaki University Hospital, Nagasaki, Japan.
  • Itonaga H; Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University, 1-12-4 Sakamoto, Nagasaki, Japan.
  • Kato T; Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University, 1-12-4 Sakamoto, Nagasaki, Japan. itonaga-ngs@umin.ac.jp.
  • Nannya Y; Department of Hematology, National Hospital Organization Nagasaki Medical Center, Omura, Japan.
  • Hashimoto M; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Kasai S; Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University, 1-12-4 Sakamoto, Nagasaki, Japan.
  • Toriyama E; Department of Hematology, Sasebo City General Hospital, Sasebo, Japan.
  • Kamijo R; Department of Hematology, Sasebo City General Hospital, Sasebo, Japan.
  • Taguchi M; Department of Hematology, Sasebo City General Hospital, Sasebo, Japan.
  • Taniguchi H; Department of Hematology, Nagasaki University Hospital, Nagasaki, Japan.
  • Sato S; Department of Hematology, Sasebo City General Hospital, Sasebo, Japan.
  • Atogami S; Department of Hematology, Nagasaki University Hospital, Nagasaki, Japan.
  • Imaizumi Y; Department of Laboratory Medicine, Sasebo City General Hospital, Sasebo, Japan.
  • Hata T; Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University, 1-12-4 Sakamoto, Nagasaki, Japan.
  • Moriuchi Y; Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University, 1-12-4 Sakamoto, Nagasaki, Japan.
  • Ogawa S; Department of Hematology, Sasebo City General Hospital, Sasebo, Japan.
  • Miyazaki Y; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Int J Hematol ; 111(2): 311-316, 2020 Feb.
Article em En | MEDLINE | ID: mdl-31515708
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Promielocítica Aguda / Aberrações Cromossômicas Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies Limite: Aged / Humans / Male Idioma: En Revista: Int J Hematol Assunto da revista: HEMATOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão País de publicação: Japão
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Promielocítica Aguda / Aberrações Cromossômicas Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies Limite: Aged / Humans / Male Idioma: En Revista: Int J Hematol Assunto da revista: HEMATOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão País de publicação: Japão